National Institute of Allergy and Infectious Diseases (NIAID)

RFA-AI-22-058: 2022 National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services, including data management and processing, safety and pharmacovigilance management and processing, and sample tracking systems for NIAID-funded clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers of immune-mediated diseases in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation.

Internal Deadline
External Deadline
11/30/2022